News/ R&D Acorda axes Parkinson’s drug after trial deaths Richard Staines Acorda, neurology, Parkinson's 0 Comment Biotech not confident white blood cell counts could ensure patient safety. Share X Acorda axes Parkinson’s drug after trial deaths https://pharmaphorum.com/news/acorda-parkinsons-trial-deaths/
News/ R&D Acorda shares crash after deaths in Parkinson’s trials Richard Staines Acorda, neurology, R&D, safety 0 Comment This could be the end for tozadenant in Parkinson’s disease. Share X Acorda shares crash after deaths in Parkinson’s trials https://pharmaphorum.com/news/acorda-shares-crash-deaths-parkinsons-trials/
News Acorda aims for leadership in Parkinson’s disease with acquisition Andrew McConaghie Acorda, Parkinson's, Parkinson's disease 0 Comment US specialist pharma company Acorda is to acquire Biotie for $363 million, a move which it hopes will Share X Acorda aims for leadership in Parkinson’s disease with acquisition https://pharmaphorum.com/news/acorda-aims-for-leadership-in-parkinsons-disease-with-acquisition/